CHOLESTECH CORPORATION
10-C, 1996-07-03
LABORATORY ANALYTICAL INSTRUMENTS
Previous: COLLABORATIVE CLINICAL RESEARCH INC, 8-K, 1996-07-03
Next: NEW YORK LIFE MFA SERIES FUND INC, 485APOS, 1996-07-03



<PAGE>


                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549


                               FORM 10-C
              REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                      INTERDEALER QUOTATION SYSTEM

               FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
             SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
                           OR 15d-17 THEREUNDER


                          CHOLESTECH CORPORATION
             (EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER)


           3347 INVESTMENT BOULEVARD, HAYWARD, CALIFORNIA 94545
                  (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

Issuer's telephone number, including area code  (510) 732-7200


                  I. CHANGE IN NUMBER OF SHARES OUTSTANDING

1. Title of Security: COMMON STOCK
2. Number of shares outstanding before the change: 8,131,824*
3. Number of shares outstanding after the change: 10,631,824
4. Effective date of change: June 28, 1996
5. Method of change: PUBLIC OFFERING OF COMMON STOCK

*As of March 31, 1996


   Give brief description of transaction: UNDERWRITTEN PUBLIC OFFERING OF 
REGISTRANT'S COMMON STOCK PURSUANT TO A REGISTRATION STATEMENT ON FORM S-1 
(REGISTRATION NO. 333-3367 FILED MAY 9, 1996, AS AMENDED BY AMENDMENT NO.1 
FILED ON JUNE 13, 1996, AMENDMENT NO. 2 FILED ON JUNE 28, 1996, AND DECLARED 
EFFECTIVE ON JUNE 28, 1996.


                 II. CHANGE IN NAME OF ISSUER

1. Name prior to change: N/A
2. Name after change: N/A
3. Effective date of charter amendment changing name: N/A
4. Date of shareholder approval of change, if required: N/A


                                             /s/ RICHARD H. JANNEY
                                             ----------------------------------
Date: JULY 3, 1996                           RICHARD H. JANNEY
                                             CHIEF FINANCIAL OFFICER



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission